Ginkgo and Bayer Sign Definitive Agreement to Build Agricultural Biologicals R&D Platform Capabilities

Ginkgo to acquire Bayer’s 175,000-square-foot Biologics R&D center and enter into a new multi-year platform collaboration with Bayer to advance several agricultural biological programs BOSTON, July 25, 2022 /PRNewswire/ — Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for…